Indications, methodology, and classification of results of tilt-table testing11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplement for a disclosure of such agents.

Richard Sutton, Daniel M Bloomfield

Open source

DOI
10.1016/s0002-9149(99)00692-x
Published
1999-10
Container
The American Journal of Cardiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0002-9149-99-00692-x,
  title = {Indications, methodology, and classification of results of tilt-table testing11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplement for a disclosure of such agents.},
  author = {Richard Sutton and Daniel M Bloomfield},
  year = {1999},
  journal = {The American Journal of Cardiology},
  doi = {10.1016/s0002-9149(99)00692-x},
  url = {https://doi.org/10.1016/s0002-9149(99)00692-x}
}

RIS

TY  - JOUR
TI  - Indications, methodology, and classification of results of tilt-table testing11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplement for a disclosure of such agents.
AU  - Richard Sutton
AU  - Daniel M Bloomfield
PY  - 1999
JO  - The American Journal of Cardiology
DO  - 10.1016/s0002-9149(99)00692-x
UR  - https://doi.org/10.1016/s0002-9149(99)00692-x
ER  - 

APA

Sutton, R., & Bloomfield, D. M. (1999). Indications, methodology, and classification of results of tilt-table testing11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplement for a disclosure of such agents.. The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(99)00692-x

Source records